Case Report On Post Covid Manifestations
Main Article Content
Abstract
Corona virus disease 2019 (COVID-19) is an infectious breathing sickness because of the corona virus 2. (SARS-CoV-2). the first recognised case become observed in Wuhan, China, in December of this year. The sickness has for the reason that spread round the arena, ensuing in a virulent disease. A giant pro-coagulant nation in addition to an inflammatory cytokine hurricane, comparable to what is seen in macrophages. As of April 20th, 2020, COVID-19 (excessive acute respiration syndrome corona virus 2 [SARSCoV2] or 2019nCoV) were detected in about 2. Four million persons round the world. the first case of COVID-19 (extreme acute respiration syndrome corona virus 2 [SARSCoV2] or 2019nCoV) turned into located in Wuhan, China. Because of its excessive infectivity, low virulence, and asymptomatic transmission, it is a completely contagious disease.
Clinical findings: A 62-year-old male patient was admitted to AVBRH with complaints of vomiting, loss of appetite, nausea, weakness, and muscle cramps, He had hypertension, diabetes mellitus.
Diagnostic Evaluation: HB-11.1 gm % , MCHC-33.5, MCV-86.9, MCH-29.1, MCHC-33.5, MCHC-33.5, MCHC-33.5, MCHC-33.5, MCHC-33.5, MCHC-33.5, MCHC-33.5, 3.83 total rbc count,HCT-33.2, RDW-14.6, total wbc count-11400Total platelet count was 0.83, Monocytes were 4 and Granulocytes were 85, 9.1 grammes of total protein (PL REPEAT)
Therapeutic Intervention: Inj Emset 4 mg, Inj Metro 100 mg BD, Inj Rein 40 mg OD, Inj pan 40 mg BD, Inj cetri 10 gm BD, Inj perinorm TDS
Outcome: The medication for vomiting, diabetes, and hypertension, as well as fever and cough, has begun. Due to the patient's weight, physiotherapy was prescribed.
Conclusion: The patient is admitted to AVBRH's medicine department and is under the care of a medical and nursing team. The patient is stable and is being monitored. The post-COVID-19 symptomatology is very similar to the post-SARS symptomatology. All COVID-19 survivors should be monitored for a long time to assess and treat any symptoms or diseases that may have been triggered by the novel corona virus infection.
Article Details
All articles published in NVEO are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.